Rahsaan Thompson - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Rahsaan Thompson has filed 2 SEC Form 4 filings across 1 company in the last 90 days - selling. Lifetime open-market sales: $495K.
Profile
Rahsaan Thompson holds the role of Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA). Thompson has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.
| Role | Chief Legal & Compliance |
|---|---|
| Notability | 34/100 |
Board memberships
- ZEVRA THERAPEUTICS, INC.
Reported roles
- Chief Legal & Compliance
Trading Pattern
InsiderAlpha's records for Rahsaan Thompson go back to 2026: 3 primary Form 4 filings, an average of 3.0 per year. 9 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Rahsaan Thompson has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA) - 3 filings, 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | ZVRA | ZEVRA THERAPEUTICS, INC. | S - Open-market sale [10b5-1] | 34.6K | $12.68 | $438K |
| 2026-06-23 | ZVRA | ZEVRA THERAPEUTICS, INC. | M - Option exercise [10b5-1] | 66.7K | - | |
| 2026-05-13 | ZVRA | ZEVRA THERAPEUTICS, INC. | S - Open-market sale [10b5-1] | 1.8K | $11.30 | $20K |
| 2026-02-02 | ZVRA | ZEVRA THERAPEUTICS, INC. | S - Open-market sale [10b5-1] | 4.1K | $8.83 | $36K |
| 2026-02-02 | ZVRA | ZEVRA THERAPEUTICS, INC. | M - Option exercise [10b5-1] | 11.3K | - |
Companies - Last 90 Days
- ZEVRA THERAPEUTICS, INC. (ZVRA) - 2 filings, last 2026-06-23
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Rahsaan Thompson has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Neil F. McFarlane - $1.19M of ZVRA open-market activity in the last 12 months
- Alvin Shih - $158K of ZVRA open-market activity in the last 12 months
- Joshua Schafer - $126K of ZVRA open-market activity in the last 12 months
- John B. Bode - $46K of ZVRA open-market activity in the last 12 months
- Timothy J. Sangiovanni - $43K of ZVRA open-market activity in the last 12 months
- Adrian W. Quartel - $40K of ZVRA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- RBC Global Asset Management (U.S.) Inc.
- Redmile Group, LLC
- Andrew Phillips Reed
- Daniel Reis-Faria
- Saul B. Rosenthal
- Jack Ross
- Martine A. Rothblatt
- Saba Capital Management, L.P.
Frequently Asked Questions
Who is Rahsaan Thompson?
Rahsaan Thompson holds the role of Chief Legal & Compliance at ZEVRA THERAPEUTICS, INC. (ZVRA). Thompson has reported 3 insider filings with the SEC since 2026. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Rahsaan Thompson submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Rahsaan Thompson been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($495K) across all tracked filings.
Where can I see all of Rahsaan Thompson's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Rahsaan Thompson profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.